Pathway Therapeutics (Anticancer Drug) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Pathway Therapeutics (Anticancer Drug) General Information

Description

Anticancer Drug molecules and its backup compounds in San Francisco. The drug molecules and its backup compounds are used as an inhibitor to slow down the growth of cancer cells and solid tumors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Acquirer
Primary Office
  • 409 Illinois Street
  • San Francisco, CA 94158
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pathway Therapeutics (Anticancer Drug) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Merger/Acquisition 14-Aug-2013 Completed Product Development
To view Pathway Therapeutics (Anticancer Drug)’s complete valuation and funding history, request access »

Pathway Therapeutics (Anticancer Drug) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Pathway Therapeutics Corporation Majority 000 0000 000000 0
To view Pathway Therapeutics (Anticancer Drug)’s complete investors history, request access »